Matches in Nanopublications for { ?s ?p "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP1411503.RADmvsXZQOOpK4Wqy6TaOwhHApbCwCMXKIUcXBWJBiNIM130_assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1411503.RADmvsXZQOOpK4Wqy6TaOwhHApbCwCMXKIUcXBWJBiNIM130_provenance.
- NP968243.RA6hAkxEyTeOiMI6lAfVrImg7rqI1Ql2ckCAlfPdh6zyA130_assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968243.RA6hAkxEyTeOiMI6lAfVrImg7rqI1Ql2ckCAlfPdh6zyA130_provenance.
- NP1411504.RA4h7PkOl5A5xJf28rWdrfV5dEZtW9Dud-NsFaAdsKnGw130_assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1411504.RA4h7PkOl5A5xJf28rWdrfV5dEZtW9Dud-NsFaAdsKnGw130_provenance.
- NP968244.RApb8DafMr_Qnc1tTglvR0pii_dkVc8RGADAFXlRqogm8130_assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968244.RApb8DafMr_Qnc1tTglvR0pii_dkVc8RGADAFXlRqogm8130_provenance.
- assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We investigated the distribution of this polymorphism, situated at position -318 to the ATG start codon and resulting in a C-T change leading to an Mse I restriction site, in both population based case control studies and family studies in patients with Graves' disease (Caucasian and Hong Kong Chinese), autoimmune hypothyroidism and systemic lupus erythematosus (SLE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.